In a study in Australia, 3-weekly paclitaxel monotherapy was associated with a similar RR, TTF, and QoL when compared with cyclophosphamide-methotrexate-5-FU-prednisone, with a trend toward an improved OS that did not reach statistical significance ( 41 ).
← all excerpts
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
1
—
—